The Opportunities in STEM campaign in partnership with Mediaplanet will be launching on June 19 in the New Scientist magazine ahead of International Women in Engineering Day.
LifeArc's newly launched B-SMArT antibody discovery platform offers collaborators a clinically validated transgenic mouse model (Kymab/Sanofi) and advanced single B-cell selection technologies (Beacon and FACS) to generate fully human antibodies ready for in vivo testing.
This nationwide initiative is calling on companies, teams, and individuals to commit to a fitness challenge while raising vital funds for translational cancer research—helping life-saving innovations move from the lab to patients faster.
